Global HIV Therapeutics Market Analysis

Global HIV Therapeutics Market Analysis


$ 3999

The Global HIV therapeutics market is expected to reach $17.029 Bn by 2030, up from $13.76 Bn in 2022, with a CAGR of 2.7% from 2022 to 2030. Global players such as ViiV Healthcare, AbbVie, Janssen Pharmaceuticals, and Gilead Sciences dominate the Global HIV therapeutics market. The global government policies, funding, poverty, and initiatives by international organizations to manage HIV infections propel the market. The Global HIV therapeutics market is divided into five segments type, product, geography, end user, and distribution channel.

ID: IN10GLPH037 CATEGORY: Pharmaceuticals GEOGRAPHY: Global AUTHOR: Vishwa Modhia

Buy Now

Global HIV Therapeutics Market Analysis Summary

HIV is a worldwide problem. The World Health Organization (WHO) estimates that 38.4 Mn people (roughly 0.7 % population) will be living with HIV in 2021, with 1.5 Mn new cases. It also estimated that 73% of those cases were receiving ART, but that 680,000 people died from HIV-related causes (such as AIDS) that same year. The global HIV therapeutics market is expected to be worth $17.029 Bn by 2030, up from $13.76 Bn in 2022, with a 2.7 % CAGR from 2022 to 2030.

That translates to 9.7 Mn people still waiting. Access to HIV treatment is critical to the global effort to eliminate AIDS as a public health threat. People with HIV who are aware of their status, take ART as prescribed, and achieve and maintain an undetectable viral load can live long and healthy lives and will not transmit HIV through sex to HIV-negative partners. Through the use of antiretroviral therapy (ART) medicines, which can keep patients healthy for many years by reducing the amount of HIV (viral load) present in the body, HIV can be controlled and treated—though not fully cured. Many nongovernmental organizations (NGOs) are involved in the global response to HIV and AIDS, including The Global Fund, International AIDS Society, Kaiser Family Foundation, UNAIDS, and World Health Organization.

Global HIV Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers Analysis

The 2021-2026 Global AIDS Strategy "End Inequalities. End AIDS" is a courageous new approach to closing the gaps that are impeding progress toward AIDS eradication. The Global AIDS Strategy seeks to address the inequalities that fuel the AIDS epidemic by prioritizing people who do not yet have access to life-saving HIV services. The President's Emergency Plan for AIDS Relief (PEPFAR) is the United States' response to the global HIV/AIDS epidemic, and it represents the largest commitment ever made by any nation to combat a single disease. These elements may entice new entrants into the Global HIV Therapeutics Market.

Market Restraints

Despite advances in our scientific understanding of HIV and its prevention and treatment, as well as years of significant effort by the global health community and leading government and civil society organizations, far too many people with HIV or at risk of HIV continue to lack access to prevention, care, and treatment, and there is no cure. Furthermore, the HIV epidemic affects not only individual health but also households, communities, and national development and economic growth. Many of the countries most affected by HIV also have other infectious diseases, food insecurity, and other serious issues.

Despite the availability of a growing number of effective HIV prevention tools and methods, as well as a massive scale-up of HIV treatment in recent years, UNAIDS warns that there has been unequal progress in reducing new HIV infections, increasing access to treatment, and ending AIDS-related deaths, with far too many vulnerable people and populations left behind. Stigma and discrimination, as well as other social inequalities and exclusion, are proving to be major impediments. These elements may deter new entrants into the Global HIV therapeutics market.

Competitive Landscape

Key Players

  • Gilead Sciences
  • Janssen Pharmaceuticals
  • AbbVie
  • Boehringer Ingelheim
  • ViiV Healthcare
  • Bristol Myers Squibb
  • Merck & Co.

Recent Notable Updates

February 2023: The FY 2024 NIH HIV/AIDS Professional Judgment Budget requests $3.673 Bn, a $479 Mn, or 15%, increase over the FY 2022 enacted budget of $3.194 Bn. HIV/AIDS research funded by the NIH has resulted in remarkable scientific discoveries, clinical advances, novel programmatic approaches, and cross-disciplinary outcomes. Additional resources requested in the FY 2024 NIH HIV/AIDS Professional Judgment Budget are critical to capitalizing on those advances and spurring further innovation in the following areas, with several highlighted scientific opportunities.

July 2022: ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi shareholders, and the Medicines Patent Pool (MPP) announced today the signing of a new voluntary licensing agreement for patents relating to cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis (PrEP) to help enable access in the least developed, low-income, lower middle-income, and Sub-Saharan African countries. This agreement allows selected generic manufacturers to develop, manufacture, and supply generic versions of cabotegravir LA for PrEP, the first long-acting HIV prevention medicine, in 90 countries. This announcement comes just seven months after the US Food and Drug Administration approved cabotegravir LA for PrEP for the first time (US FDA).

Healthcare Regulations

The regulatory landscape for HIV therapeutics varies by country and region.

The Food and Drug Administration (FDA) in the United States is in charge of regulating the safety and efficacy of drugs. It reviews and approves all new HIV drugs before they are released to the public. European Medicines Agency (EMA) is in charge of regulating drug approval and use in the European Union. It reviews and approves all new HIV drugs before they are released to the public.

World Health Organization (WHO): The WHO provides global guidance and recommendations on HIV drug use. It collaborates with countries and organizations to increase access to and proper use of HIV medications. NRAs (National Regulatory Authorities): Individual countries' NRAs are in charge of regulating drug approval and use. They review and approve all new HIV drugs before they are sold on the market, and they monitor how these drugs are used in their respective countries.

Reimbursement Policies

The reimbursement of HIV therapeutics varies across different countries and healthcare systems. There are, however, some global initiatives aimed at increasing access to HIV treatment and ensuring reimbursement for those in need. The World Health Organization's (WHO) "treat all" policy, which recommends that all people living with HIV be offered antiretroviral therapy, is one such initiative (ART). Furthermore, some countries have national health insurance schemes or other reimbursement programs that cover the cost of HIV therapeutics such as ART and other medications used to treat HIV-related conditions.

The United States President's Emergency Plan for AIDS Relief (PEPFAR), is a U.S. government initiative that provides funding for HIV treatment, prevention, and care in low- and middle-income countries. the Global Fund to Fight AIDS, Tuberculosis, and Malaria, which is a non-profit international organisation that provides funding to support programs that address these three diseases, organisations worldwide.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

HIV Therapeutics Segmentation

By Types (Revenue, USD Billion):

  • Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
  • Coreceptor Antagonists
  • Entry and Fusion Inhibitors
  • Integrase Inhibitors
  • Protease Inhibitors (PIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 22 February 2023
Updated by: Jay Dalwadi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up